Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| First-In-Human (FIH), Single Ascending Dose (SAD) Study and Multiple Ascending Dose (MAD) Study of SP-101 Injection (NCT07334249) | Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd. | 2025-12-23 |
Track Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.